Page 9 - 2019_08-Haematologica-web

haematologica Journal of the Ferrata Storti Foundation
e340 Differential effects of therapeutic complement inhibitors on serum bactericidal activity against non-groupable meningococcal isolates recovered from patients treated with eculizumab
Dan M. Granoff et al.
http://www.haematologica.org/content/104/8/e340
e345 TP53 immunohistochemistry correlates with TP53 mutation status and clearance in decitabine-treated patients with myeloid malignan- cies
Marianna B. Ruzinova et al. http://www.haematologica.org/content/104/8/e345
e349 Tracking myeloid malignancies by targeted analysis of successive DNA methylation at neighboring CG dinucleotides Monika Eipel et al.
http://www.haematologica.org/content/104/8/e349
e352 CD371 cell surface expression: a unique feature of DUX4-rearranged acute lymphoblastic leukemia Dagmar Schinnerl et al.
http://www.haematologica.org/content/104/8/e352
e356 Long-term follow up after third-party viral-specific cytotoxic lymphocytes for immunosuppression- and Epstein-Barr virus-associated lymphoproliferative disease
Sajida Kazi et al. http://www.haematologica.org/content/104/8/e356
e360 Post-transplant outcome of ovarian tissue cryopreserved after chemotherapy in hematologic malignancies Catherine Poirot et al.
http://www.haematologica.org/content/104/8/e360
e364 Ectopic ATP synthase β subunit proteins on human leukemia cell surface interact with platelets by binding glycoprotein IIb Ting Wang et al.
http://www.haematologica.org/content/104/8/e364
e369 Role of factor VIII-binding capacity of endogenous von Willebrand factor in the development of factor VIII inhibitors in patients with severe hemophilia A
Yohann Repessé et al. http://www.haematologica.org/content/104/8/e369
Case Reports
Case Reports are available online only at www.haematologica.org/content/104/8.toc
e373 Shared cell of origin in a patient with Erdheim-Chester disease and acute myeloid leukemia Armin Ghobadi et al.
http://www.haematologica.org/content/104/8/e373
e376 Epstein-Barr virus-associated lymphoproliferative disease during imatinib mesylate treatment for chronic myeloid leukemia Junko Yamaguchi et al.
http://www.haematologica.org/content/104/8/e376
e380 Rescue factor VIII replacement to secure hemostasis in a patient with hemophilia A and inhibitors on emicizumab prophylaxis undergoing hip replacement
Elena Santagostino et al. http://www.haematologica.org/content/104/8/e380
Comment
Comment is available online only at www.haematologica.org/content/104/8.toc
e383 Tamoxifen erythroid toxicity revealed by studying the role of nuclear receptor co-activator 4 in erythropoiesis Antonella Nai et al.
http://www.haematologica.org/content/104/8/e383
Haematologica 2019; vol. 104 no. 8 - August 2019 http://www.haematologica.org/